| |
| |
|
| Insider
Information: |
Mason Michael |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
399,319 |
|
|
Indirect Shares
|
276 |
|
|
| Direct
Value |
$515,281 |
|
|
|
Indirect Value
|
$41,486 |
|
|
| Total
Shares |
399,595 |
|
|
| Total
Value |
$556,767 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-13.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -588.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
VP, Finance and Treasu... |
2018-08-13 |
563 |
2018-07-10 |
276 |
Premium* |
|
|
Karyopharm Therapeutics Inc. |
KPTI |
|
2024-03-01 |
398,756 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2024-03-01 |
4 |
S |
$1.20 |
$7,394 |
D/D |
(6,162) |
398,756 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2024-02-29 |
4 |
S |
$1.17 |
$32,394 |
D/D |
(27,687) |
404,918 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
188,205 |
432,605 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2024-02-27 |
4 |
S |
$1.32 |
$3,369 |
D/D |
(2,545) |
244,400 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2024-02-06 |
4 |
S |
$1.59 |
$6,671 |
D/D |
(4,205) |
246,945 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2024-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
13,333 |
251,150 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2023-09-01 |
4 |
S |
$1.33 |
$9,203 |
D/D |
(6,913) |
237,817 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2023-06-02 |
4 |
S |
$2.22 |
$1,401 |
D/D |
(631) |
244,730 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2023-03-01 |
4 |
S |
$3.03 |
$33,942 |
D/D |
(11,205) |
245,361 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
95,000 |
256,566 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2023-02-27 |
4 |
S |
$3.04 |
$8,509 |
D/D |
(2,802) |
161,566 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2023-02-06 |
4 |
S |
$3.40 |
$14,079 |
D/D |
(4,141) |
164,368 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
168,509 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO, Treasurer |
• – – |
2022-06-03 |
4 |
S |
$6.04 |
$3,630 |
D/D |
(601) |
138,509 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
88,200 |
141,508 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2022-02-28 |
4 |
S |
$10.24 |
$24,550 |
D/D |
(2,398) |
139,110 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
• – – |
2022-02-07 |
4 |
S |
$9.86 |
$38,925 |
D/D |
(3,947) |
53,308 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CFO, Treasurer |
• – – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
57,255 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, CFO & Treasurer |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
22,013 |
51,755 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, CFO & Treasurer |
• – – |
2021-02-11 |
4 |
S |
$15.52 |
$44,354 |
D/D |
(2,858) |
5,292 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, CFO & Treasurer |
• – – |
2021-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,150 |
8,150 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
• – – |
2018-08-13 |
4 |
D |
$90.95 |
$40,837 |
D/D |
(449) |
563 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
• – – |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,012 |
1,012 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
• – – |
2018-07-10 |
4 |
A |
$0.00 |
$0 |
I/I |
23 |
276 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
• – – |
2018-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
22 |
253 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
